Kyowa Hakko’s nootropic included in Nootropics Depot capsule and powder forms 

Kyowa Hakko’s nootropic included in Nootropics Depot capsule and powder forms 

25 Sep 2018 --- Kyowa Hakko’s Cognizin Citicoline is now featured in two new products sold at Nootropics Depot. The supplements vendor now offers Cognizin Citicoline Powder in 30g and 60g jars, as well as Cognizin Citicoline Capsules, which contain 250mg of this brain health ingredient and come in 60- or 180-count jars. Brain health is a growing category for product launches, and within this space, nootropics are gaining recognition for their ability to provide a mental boost.

Citicoline is a nootropic naturally occurring in the body's cells and is especially vital to brain health and cognitive function. Cognizin Citicoline is touted as providing nutritional support that benefits mental processes, focus and concentration, as well as healthy brain metabolism.

Click to EnlargeKyowa Hakko sees the market for nootropics and brain foods expanding thanks to growing interest in the eSport sector and the company’s customers are offering various products fulfilling targeting this market. 

“In today's hyperactive world where we are all connected 24/7, there is huge interest in maximizing the power of one's brain. Staying attentive and mentally sharp as long as possible is high on many people's agendas. This used to be mainly aimed at learning, but a massive new market has emerged in the eSports sector,” Oksana Ritchie, European Marketing Manager at Kyowa Hakko, tells NutritionInsight.

“Played by hundreds of millions worldwide it has transformed from being something younger people did on the bus on the way home to a multi-billion dollar industry where events can attract crowds of tens of thousands. It's even being proposed as a new Olympic sport. Supporting cognitive adaptability and improving mental sharpness are considered to be essential with shots of caffeine no longer being the only option,” she adds.

“Many of their new product formulas now contain Cognizin Citicoline, a brain ingredient which is GRAS and EU Novel Food [status] approved. It is a non-stimulant in comparison to caffeine and has been clinically proven to improve attention, focus and motor speed. Citicoline also improves the phospholipid balance which is essential for normal brain function,” Ritchie says.

Cognizin has been studied in a variety of human clinical trials, with the most recent human clinical trial focusing on the benefits of Cognizin on healthy, middle-aged men and women. 

Conducted at the Brain Imaging Center at McLean Hospital, researchers found increases in brain activity among participants that had taken a Cognizin supplement for six weeks. Differences were noticeable in those participants that performed tasks that required sustained attention. 

Kyowa Hakko also reports that clinical trials have also found that Cognizin Citicoline supports healthy mitochondrial function. Healthy mitochondrial function results in higher levels of ATP (Adenosine triphosphate) – our bodies primary energy storage molecule – in brain cells. 

To contact our editorial team please email us at editorial@cnsmedia.com


Supplier Profiles On NutritionInsight.com
Kyowa Hakko Europe GmbH

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jul 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. This week, a mental boost supplement launched,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 Jul 2018 --- Cognitive health has proven itself a growing category, with new products appealing to consumers from all walks of life, from more senior citizens seeking to prevent... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 May 2018 --- Boundaries are blurring as sports nutrition continues to move mainstream. Ingredients and products aimed at promoting active living were a clear standout theme at... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

05 Dec 2017 --- Following the launch of its flagship Setria Glutathione product, Kyowa Hakko is keenly watching and helping build the European market for immunity, beauty and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Aug 2017 --- A 500mg dose of citicoline from Kyowa Hakko Europe (Kyowa) may significantly slow the progression of visual acuity loss due to glaucoma. This is according to a new... Read More